354 related articles for article (PubMed ID: 25890625)
21. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
[TBL] [Abstract][Full Text] [Related]
22. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
[TBL] [Abstract][Full Text] [Related]
23. A case of severe Stevens-Johnson syndrome successfully treated by osteo-odonto-keratoprosthesis surgery.
Fukuda M; Nakao A; Hamada S; Liu C; Shimomura Y
Jpn J Ophthalmol; 2005; 49(5):423-4. PubMed ID: 16187047
[No Abstract] [Full Text] [Related]
24. Managing laminar resorption in osteo-odonto-keratoprosthesis.
Avadhanam V; Liu C
Am J Ophthalmol; 2014 Aug; 158(2):213-214.e2. PubMed ID: 25085104
[No Abstract] [Full Text] [Related]
25. Idiopathic vitritis in the setting of Boston keratoprosthesis.
Grassi CM; Crnej A; Paschalis EI; Colby KA; Dohlman CH; Chodosh J
Cornea; 2015 Feb; 34(2):165-70. PubMed ID: 25526075
[TBL] [Abstract][Full Text] [Related]
26. Vitreoretinal Complications in Boston Keratoprosthesis Type 1.
Khair D; Salimi A; Harissi-Dagher M
Am J Ophthalmol; 2021 Nov; 231():101-108. PubMed ID: 34107311
[TBL] [Abstract][Full Text] [Related]
27. Osteo-odonto-keratoprosthesis for end-stage cornea blindness.
Wong HS; Then KY; Ramli R
Med J Malaysia; 2011 Oct; 66(4):369-70. PubMed ID: 22299563
[TBL] [Abstract][Full Text] [Related]
28. Chronic hypotony associated with the Boston type 1 keratoprosthesis.
Dokey A; Ramulu PY; Utine CA; Tzu JH; Eberhart CG; Shan S; Gelhbach PL; Akpek EK
Am J Ophthalmol; 2012 Aug; 154(2):266-271.e1. PubMed ID: 22633347
[TBL] [Abstract][Full Text] [Related]
29. Vitreoretinal complications of osteoodontokeratoprosthesis surgery.
Hughes EH; Mokete B; Ainsworth G; Casswell AG; Eckstein MB; Zambarakji HJ; Gregor Z; Rosen PH; Herold J; Okera S; Liu CS
Retina; 2008 Oct; 28(8):1138-45. PubMed ID: 18779721
[TBL] [Abstract][Full Text] [Related]
30. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
[TBL] [Abstract][Full Text] [Related]
31. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
[TBL] [Abstract][Full Text] [Related]
32. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
33. Keratoprosthesis: Current global scenario and a broad Indian perspective.
Iyer G; Srinivasan B; Agarwal S; Talele D; Rishi E; Rishi P; Krishnamurthy S; Vijaya L; Subramanian N; Somasundaram S
Indian J Ophthalmol; 2018 May; 66(5):620-629. PubMed ID: 29676302
[TBL] [Abstract][Full Text] [Related]
34. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
Aravena C; Bozkurt TK; Yu F; Aldave AJ
Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
[TBL] [Abstract][Full Text] [Related]
36. [Keratoprostheses: Last Hope for the Most Severe Corneal Diseases].
Bachmann B; Schaub F; Cursiefen C
Klin Monbl Augenheilkd; 2022 Sep; 239(9):1165-1179. PubMed ID: 35970191
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of penetrating keratoplasty and vitreoretinal surgery with Eckardt temporary keratoprosthesis in ocular trauma versus non-trauma patients.
Bové Álvarez M; Arumí CG; Distéfano L; Güell JL; Gris Ó; Mateo C; Corcóstegui B; García-Arumí J
Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2547-2558. PubMed ID: 31363832
[TBL] [Abstract][Full Text] [Related]
38. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
Greiner MA; Li JY; Mannis MJ
Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
[TBL] [Abstract][Full Text] [Related]
39. Medium term results in keratoprostheses with biocompatible and biological haptic.
Hille K; Hille A; Ruprecht KW
Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):696-704. PubMed ID: 16308693
[TBL] [Abstract][Full Text] [Related]
40. Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation.
Lenis TL; Chiu SY; Law SK; Yu F; Aldave AJ
Ophthalmology; 2017 Jan; 124(1):12-19. PubMed ID: 27614591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
